Omvoh 300 mg concentrate for solution for infusion, Omvoh 100 mg solution for injection in pre-filled syringe
I6T-MC-AMBA
Phase 3 small_molecule active
Quick answer
Omvoh 300 mg concentrate for solution for infusion, Omvoh 100 mg solution for injection in pre-filled syringe for Moderately to Severely Active Ulcerative Colitis is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Moderately to Severely Active Ulcerative Colitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active